Clinical updates in primary biliary cholangitis: Trends, epidemiology, diagnostics, and new therapeutic approaches

Artin Galoosian, Courtney Hanlon, Julia Zhang, Edward W. Holt, Kidist K. Yimam

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Abstract

Primary biliary cholangitis, formerly known as primary biliary cirrhosis, is a chronic, autoimmune, and cholestatic disease ameliorating the biliary epithelial system causing fibrosis and end-stage liver disease, over time. Patients range from an asymptomatic phase early in the disease course, to symp-toms of decompensated cirrhosis later in its course. This review focuses on the current consensus on the epidemiology, diagnosis, and management of patients with primary biliary cholangitis. We also discuss established medical management as well as novel and investigational therapeutics in the pipeline for management of PBC.

Original languageEnglish (US)
Pages (from-to)49-60
Number of pages12
JournalJournal of Clinical and Translational Hepatology
Volume8
Issue number1
DOIs
StatePublished - 2020
Externally publishedYes

Keywords

  • Epidemiology
  • Obeticholic acid
  • Primary biliary cholangitis (PBC)
  • Treatment
  • UDCA

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Clinical updates in primary biliary cholangitis: Trends, epidemiology, diagnostics, and new therapeutic approaches'. Together they form a unique fingerprint.

Cite this